In fact, in ESCC patients, increased PD-L1 or PD-L2 expression in ESCC cells is correlated with reduced survival, while increased PD-L1 expression is associated with increased depth of tumor invasion and worse survival (142, 143). The gene discussed is PDCD1LG2; the disease is esophageal squamous cell carcinoma.